Приказ основних података о документу

QSAR study of imidazoline antihypertesive drugs

dc.creatorFilipić, Slavica
dc.creatorNikolić, Katarina
dc.creatorAgbaba, Danica
dc.date.accessioned2023-11-20T13:50:15Z
dc.date.available2023-11-20T13:50:15Z
dc.date.issued2009
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5246
dc.description.abstractThe hypotensive effect of imidazoline ligands was attributed both to α2-adrenergic receptors and nonadrenergic imidazoline-1 receptors (I1-R). ...sr
dc.language.isoensr
dc.publisherEuropean Federation for Medicinal Chemistrysr
dc.relationinfo:eu-repo/grantAgreement/MESTD/MPN2006-2010/142071/RS//sr
dc.rightsrestrictedAccesssr
dc.sourceVienna Summer School Drug Design 2009sr
dc.subjectimidazoline ligandssr
dc.subjectQSARsr
dc.subjectantihypertensivessr
dc.subjectmultilinear regression modelsr
dc.titleQSAR study of imidazoline antihypertesive drugssr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.description.otherVienna Summer School for Drug Design, September 13 - September 18 2009, Vienna, Austriasr
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_farfar_5246
dc.type.versionpublishedVersionsr


Документи

Thumbnail
Име:
QSAR_study_of_pub_2009.pdf
Величина:
725.9Kb
Формат:
PDF
Отварање

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу